Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Monthly Archives: November 2016

New Survey: U.S. Dementia Rates Are Dropping Even as Population Ages

dementia-2New York, NY, November 24, 2016 — Gina Kolata reports in The New York Times that despite fears that dementia rates were going to explode as the population grows older and fatter, and has more diabetes and high blood pressure, a large nationally representative survey has found the reverse.

Dementia is actually on the wane. And when people do get dementia, they get it at older and older ages.

Kolata reports that previous studies found the same trend but involved much smaller and less diverse populations like the mostly white population of Framingham, Mass., and residents of a few areas in England and Wales. Continue reading

FDA Research May Help Speed Development of Zika Vaccines and Therapeutics

Zika 3Washington, DC, November 23, 2016 — A new mouse model developed by scientists at the U.S. Food and Drug Administration (FDA) may help in exploring the potential activity of Zika virus vaccines and therapeutics.

Published last week in PLoS Pathogens, is the description of a neonatal mouse model that provides a platform for potentially improving and expediting studies to understand the causes and effects (pathology) of the Zika virus.

The recent spread of the Zika virus and its association with increased rates of neurological disorders and complex congenital syndromes, such as microcephaly in babies and Guillain-Barré Syndrome in adults, has created an urgent need for animal models to examine the virus’ pathology. Continue reading

Gov. Christie Saves Pennsylvania Reciprocity Agreement After Achieving Over $250M in Taxpayer Savings

Governor Chris Christie

Governor Chris Christie

Trenton, NJ, November 22, 2016 — Governor Chris Christie announced today that he is now able to save the income tax reciprocity agreement with Pennsylvania, thanks to health benefit reforms enacted since the FY17 budget passed.

In September, the State Health Benefits Commission and Plan Design Committee identified and enacted healthcare reforms to save State taxpayers over $200 million for Calendar Year 2017 ($100.5 million for Fiscal Year 2017). Continue reading

GEN Publishes 2016 Top 10 U.S. Biopharma Clusters List; New Jersey/New York Ranked No. 3

New Jersey pin horizontalNew Rochelle, NY, November 22, 2016Genetic Engineering & Biotechnology News (GEN) has published its 2016 Top 10 US Biopharma Clusters list.  New Jersey/New York is number three on the list, the same position it was on GEN’s 2015 Top 10 list.

This year’s Top 10 are:

  1. Boston-Cambridge
  2. San Francisco Bay Area
  3. New Jersey/New York
  4. Maryland/DC Metro
  5. San Diego
  6. Greater Philadelphia
  7. Seattle
  8. Raleigh/Durham
  9. Los Angeles/Orange County
  10. Chicagoland Continue reading

Sweeney-Greenstein’s Cost-Saving Bill for Prescription Drugs Goes to Governor

trenton-cap-capTrenton, NJ, November 21, 2016 — The Assembly today approved a plan that would save at least $200 million in prescription drug costs by rooting out profiteering by drug companies and the “pharmaceutical benefit manager” responsible for purchasing and supplying medications for public employees in New Jersey.

The reforms are contained in legislation, S2749 / A4328, sponsored by Senate President Steve Sweeney and Senator Linda Greenstein in the Senate and Assembly Speaker Vincent Prieto in the Assembly, that was approved with a vote of 71 – 0.

It now goes to the governor. Continue reading

Senate HELP Committee Chairman Says Replacing Obamacare Could Take Years

obamacare-repeal-2Washington, DC, November 21, 2016 — Jordain Carney reports in The Hill that Sen. Lamar Alexander (R-Tennessee), the Chairman of the Health, Education, Labor and Pensions (HELP) Committee, is predicting it will take years to repeal and replace Obamacare, with Republicans needing support from Democrats to approve a new healthcare law.

“I imagine [it] will take several years to completely make that sort of transition to make sure we do no harm, create a good healthcare system that everyone has access to and we repeal the parts of ObamaCare that need to be repealed,” Chairman Alexander told reporters on Thursday. Continue reading

New Jersey Senate Passes Pharmacy Benefits Manager Legislation

Trenton Capital Dome  MoonTrenton, NJ, November 20, 2016Katie Jennings reported on Politico New Jersey that the full New Jersey Senate passed a bill on Monday, November 14 to alter the contract for the pharmacy benefits manager (PBM) — the company that processes and manages prescription drugs claims — for the state health plans for public workers and teachers.

The bill (S2749), which has the backing of the public employee unions, directs the Division of Purchase and Property in the state treasury department to procure a pharmacy benefits manager contract “in an expedited process” that includes “reverse auction” bidding, technology that allows for competitive bidding on drug prices in real-time.

Senate President Stephen Sweeney sponsored the bill.  The bill passed by a vote of 34-0. Continue reading

New Report: Fewer U.S. Children Lack Access to Healthcare

doctor-kid-2Washington, DC, November 19, 2016 — As a growing number of U.S. children have gained health insurance over the past decade, fewer kids are missing out on things like physicals and dental exams, a recent study suggests.

Steep declines in the number of uninsured have been well documented, largely as a result of growth in Medicaid and the Children’s Health Insurance Program (CHIP).

But the current study offers fresh evidence that kids are not only getting insured — they’re also becoming more likely to receive the care they need. Continue reading

Dr. Steven Libutti to Serve Dual Rutgers Roles: Cancer Institute Director and Rutgers Biomedical and Health Sciences Vice Chancellor

Dr. Steven K. Libutti

Dr. Steven K. Libutti

New Brunswick, NJ, November 18, 2016 — Aiming to further propel scientific discovery as well as augment and expand comprehensive cancer services for patients through collaborative efforts with Rutgers and RWJBarnabas Health, Steven K. Libutti, M.D., FACS, has been named to serve in the dual positions of Director of Rutgers Cancer Institute of New Jersey and of Vice Chancellor for Cancer Programs for Rutgers Biomedical and Health Sciences.

When he takes on his new roles in early 2017, Dr. Libutti will be the third permanent director in the 25-year history of Rutgers Cancer Institute of New Jersey and will take over for Bruce G. Haffty, MD, who has been serving as interim director and will continue his role as Chair of Radiation Oncology.

Dr. Libutti also will have an appointment as a Professor of Surgery at Rutgers Robert Wood Johnson Medical School. Continue reading

Surgeon General Issues Landmark Report on Alcohol, Drugs and Health

U.S. Surgeon General Dr. Vivek Murthy

U.S. Surgeon General Dr. Vivek Murthy

Washington, DC, November 18, 2016 — A new Surgeon General’s report released on November 16 finds alcohol and drug misuse and severe substance use disorders, commonly called addiction, to be one of America’s most pressing public health concerns.

Nearly 21 million Americans — more than the number of people who have all cancers combined — suffer from substance use disorders.

The new report, Facing Addiction in America: The Surgeon General’s Report on Alcohol, Drugs, and Health, marks the first time a U.S. Surgeon General has dedicated a report to substance misuse and related disorders. Continue reading